News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
879,891 Results
Type
Article (88579)
Company Profile (815)
Press Release (790462)
Multimedia
Podcasts (228)
Webinars (34)
Section
Business (233507)
Career Advice (4158)
Deals (39948)
Drug Delivery (172)
Drug Development (91613)
Employer Resources (207)
FDA (18514)
Job Trends (17470)
News (398516)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3043)
Academic (2)
Accelerated approval (48)
Adcomms (39)
Allergies (183)
Alliances (56987)
ALS (221)
Alzheimer's disease (1924)
Antibody-drug conjugate (ADC) (490)
Approvals (18795)
Artificial intelligence (799)
Autoimmune disease (297)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (237)
Biotechnology (486)
Bladder cancer (195)
Brain cancer (80)
Breast cancer (786)
Cancer (6110)
Cardiovascular disease (519)
Career advice (3590)
Career pathing (48)
CAR-T (353)
CDC (75)
Celiac Disease (3)
Cell therapy (986)
Cervical cancer (48)
Clinical research (78348)
Collaboration (2238)
Company closure (8)
Compensation (1412)
Complete response letters (100)
COVID-19 (3026)
CRISPR (118)
C-suite (1176)
Cystic fibrosis (162)
Data (7882)
Decentralized trials (3)
Denatured (86)
Depression (184)
Dermatology (83)
Diabetes (628)
Diagnostics (7494)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (391)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (298)
Earnings (101946)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137405)
Executive appointments (1153)
FDA (22337)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1836)
Gene editing (258)
Generative AI (85)
Gene therapy (804)
GLP-1 (1241)
Government (5538)
Grass and pollen (8)
Guidances (410)
Healthcare (21081)
HIV (87)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (344)
Immuno-oncology (100)
Indications (180)
Infectious disease (3399)
Inflammatory bowel disease (239)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (298)
Interviews (820)
IPO (17988)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (110)
Layoffs (676)
Leadership (49)
Legal (10171)
Liver cancer (107)
Longevity (35)
Lung cancer (803)
Lymphoma (434)
Machine learning (63)
Management (66)
Manufacturing (1120)
MASH (202)
Medical device (15215)
Medtech (15330)
Mergers & acquisitions (23208)
Metabolic disorders (1674)
mRNA (241)
Multiple sclerosis (196)
NASH (24)
Neurodegenerative disease (463)
Neuropsychiatric disorders (124)
Neuroscience (3557)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5137)
Now hiring (78)
Obesity (813)
Opinion (366)
Ovarian cancer (221)
Pain (271)
Pancreatic cancer (308)
Parkinson's disease (384)
Partnered (39)
Patents (618)
Patient recruitment (690)
Peanut (66)
People (67705)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24206)
Phase 2 (34031)
Phase 3 (25598)
Pipeline (8405)
Policy (382)
Postmarket research (3558)
Preclinical (10895)
Press Release (72)
Prostate cancer (310)
Psychedelics (68)
Radiopharmaceuticals (351)
Rare diseases (1179)
Real estate (7456)
Recruiting (81)
Regulatory (30028)
Reports (76)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (37)
RNA editing (26)
RSV (98)
Schizophrenia (191)
Series A (312)
Series B (224)
Service/supplier (30)
Sickle cell disease (120)
Special edition (30)
Spinal muscular atrophy (188)
Sponsored (54)
Startups (4362)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (139)
Vaccines (1262)
Venture capital (122)
Weight loss (560)
Women's health (129)
Worklife (24)
Date
Today (208)
Last 7 days (968)
Last 30 days (3445)
Last 365 days (33248)
2026 (12240)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1295)
Alabama (100)
Alaska (7)
Arizona (386)
Arkansas (16)
Asia (52047)
Australia (9155)
California (13534)
Canada (3812)
China (1424)
Colorado (586)
Connecticut (599)
Delaware (415)
Europe (119993)
Florida (2006)
Georgia (442)
Hawaii (4)
Idaho (69)
Illinois (1163)
India (97)
Indiana (632)
Iowa (25)
Japan (540)
Kansas (139)
Kentucky (56)
Louisiana (46)
Maine (87)
Maryland (1662)
Massachusetts (9883)
Michigan (407)
Minnesota (757)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (146)
New Hampshire (92)
New Jersey (3615)
New Mexico (33)
New York (3562)
North Carolina (1836)
North Dakota (10)
Northern California (6663)
Ohio (421)
Oklahoma (26)
Oregon (55)
Pennsylvania (2692)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5290)
Tennessee (216)
Texas (2184)
United States (48563)
Utah (405)
Vermont (1)
Virginia (346)
Washington D.C. (88)
Washington State (1121)
West Virginia (4)
Wisconsin (152)
Wyoming (2)
There are 879,891 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
Fibrosis, IPF and the search for better therapies
In this episode of Denatured, you’ll be hearing from Georg Vo Beiske, CEO of Tribune Therapeutics and Jonas Hallén, co-founder and Chief Medical Officer of Calluna Pharma. We dive into IPF and fibrosis challenges, unpacking treatment hurdles, emerging targets, unmet needs and expansion paths beyond the lung.
May 7, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
Increased capital boosts biotech R&D job postings, employment
Biotech R&D job postings live on
BioSpace
rose
for the fourth straight month in April, and a CBRE report shared similar findings for employment. The head of CBRE’s U.S. life sciences practice discusses what’s behind the growth and the current job market.
May 7, 2026
·
4 min read
·
Angela Gabriel
Career Advice
Winning the room: how to ace panel interviews
Panel interviews can play a major role in getting jobs. Two career coaches discuss what to do before and during the interview, including identifying how to differentiate yourself, engaging in true conversations and not overlooking a key panel member.
May 7, 2026
·
5 min read
·
Angela Gabriel
Press Releases
Vicore Pharma Elects Peter Guenter to its Board of Directors
May 7, 2026
·
3 min read
Press Releases
Spago Nanomedical Interim Report January-March 2026
May 7, 2026
·
6 min read
Press Releases
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
May 7, 2026
·
5 min read
Press Releases
Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
May 7, 2026
·
9 min read
Press Releases
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
·
16 min read
Press Releases
Zelluna ASA: First Quarter 2026 results
May 7, 2026
·
3 min read
Press Releases
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
May 7, 2026
·
6 min read
1 of 87,990
Next
